Compare FOFO & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOFO | DTIL |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.2M | 97.7M |
| IPO Year | N/A | N/A |
| Metric | FOFO | DTIL |
|---|---|---|
| Price | $4.13 | $4.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 22.1K | ★ 211.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | $10.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.86 | $3.53 |
| 52 Week High | $68.00 | $8.82 |
| Indicator | FOFO | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 27.18 | 48.88 |
| Support Level | $3.90 | $3.62 |
| Resistance Level | $5.70 | $4.11 |
| Average True Range (ATR) | 0.58 | 0.25 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 5.90 | 76.42 |
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.